Update on antimalarials and systemic lupus erythematosus

Purpose of review The purpose of this review is highlighting the most recent evidence on the clinical efficacy and toxicity of antimalarials in systemic lupus erythematosus (SLE). Recent findings New data confirm the effects of antimalarials in preventing SLE activity, damage and infections and in decreasing mortality. An important reduction in use of health resources is related to continued antimalarial use. Hydroxychloroquine (HCQ) may prevent preeclampsia in pregnant women with SLE. HCQ ocular toxicity is infrequent and could be associated with blood levels. Gastrointestinal and skin toxicity are underrecognized and could influence adherence. Prolongation of QT interval is extremely unusual with HCQ. Doses of HCQ of 200 mg/day seem to offer a good efficacy/toxicity balance. HCQ protection against herpes zoster and Pneumocystis jirovecii infection has been shown. On the contrary, HCQ prescription by doctors and adherence by patients are both under recommended standards. The recent coronavirus disease 2019 pandemic has resulted in a significant shortage of HCQ in many countries with possible consequences in the correct treatment of lupus patients. Summary Recent evidence reinforces the central role of HCQ in SLE therapy. The reduction in activity, damage accrual and mortality is consistent across studies, countries and ethnical groups. On the contrary, and despite the well established beneficial effects of prolonged regular HCQ therapy, many SLE patients do never t...
Source: Current Opinion in Rheumatology - Category: Rheumatology Tags: SYSTEMIC LUPUS ERYTHEMATOSUS AND SJOGREN SYNDROME: Edited by Mariana J. Kaplan Source Type: research

Related Links:

Health care systems have encountered unprecedented challenges during the coronavirus disease-2019 (COVID-19) pandemic, such as standardizing care in the absence of high-quality data. As an emblematic example, preliminary data and early anecdotal experience suggested that a major driver of COVID-19 pathophysiology was hypercoagulability, suggesting the need for aggressive anticoagulation. In this article, we describe the rapid guidance process for the development of an anticoagulation protocol for COVID-19. Preliminary evidence was collected from multidisciplinary experts within our institution to inform the first protocol ...
Source: Quality Management in Healthcare - Category: Health Management Tags: Commentary Source Type: research
Source: BMJ Comments - Category: General Medicine Source Type: forums
AbstractThe COVID-19 pandemic has called for and generated massive novel government regulations to increase social distancing for the purpose of reducing disease transmission. A number of studies have attempted to guide and measure the effectiveness of these policies, but there has been less focus on the overall efficiency of these policies. Efficient social distancing requires implementing stricter restrictions during periods of high viral prevalence and rationing social contact to disproportionately preserve gatherings that produce a good ratio of benefits to transmission risk. To evaluate whether U.S. social distancing ...
Source: Risk Analysis - Category: International Medicine & Public Health Authors: Tags: Original Research Article Source Type: research
A federal appeals court has issued a temporary injunction against a Covid-19 vaccine mandate for New York City educators set to go into...
Source: Reuters: Health - Category: Consumer Health News Source Type: news
According to the British Dietetic Association, the average adult needs roughly 150 micrograms of the mineral daily - while women who are pregnant or breastfeeding need 200 micrograms.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Alaska, where ICU hospitalizations rose 14%, has the highest rate of Covid-19 cases by far.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation Breaking breaking-news Coronavirus Source Type: news
Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans’ protection against the virus
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
Some districts have established robust virus testing programs, but many others are struggling.
Source: NYT Health - Category: Consumer Health News Authors: Tags: your-feed-science Tests (Medical) Education (K-12) Contact Tracing (Public Health) Coronavirus Risks and Safety Concerns Coronavirus (2019-nCoV) Coronavirus Reopenings Children and Childhood your-feed-health your-feed-education Chicago Source Type: news
Government scientists have recommended a third dose of Covid-19 vaccine for a select group. Find out if you qualify.
Source: Reuters: Health - Category: Consumer Health News Source Type: news
DELIRIUM is highly likely for patients hospitalised for COVID-19 and could be lasting, according to a new study.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
More News: Coronavirus | COVID-19 | Gastroenterology | Herpes | Hydroxychloroquine | Lupus | Pandemics | Pregnancy | Rheumatology | Sjogren's Syndrome | Skin | Study | Toxicology | Women